Compared with the CFS model group, 32-day SI treatment strongly upregulated the expression of Nrf2 and the content of four antioxidant enzymes in the liver (P < 0.01; Figure 4). The gene discussed is NFE2L2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.